The expansive surface area-to-volume ratio significantly enhances drug dissolution and facilitates faster, more efficient penetration across biological barriers, leading to improved bioavailability.
Nanoemulsion based Targeted Drug Delivery Solution for Targeted Delivery
In the dynamic pursuit of groundbreaking therapies, overcoming the delivery challenge for poorly soluble or sensitive therapeutic agents is paramount. Our Nanoemulsion-based Delivery Systems Solution helps you accelerate drug formulation and enhance therapeutic efficacy through precise control over droplet size and superior encapsulation technology. This advanced colloidal platform is essential for boosting drug solubility, stability, and bioavailability across diverse administration routes, providing a clear path from compound to clinic.
Click Here to View more about our Services
Introduction of Nanoemulsion Delivery Systems
Nanoemulsions are advanced colloidal drug carriers consisting of nanometer-sized droplets, typically ranging from 20 to 200 nm, dispersed in an immiscible liquid, and stabilized by a surfactant and co-surfactant mixture. They can be formulated as oil-in-water (O/W) or water-in-oil (W/O) systems.
Fig.1 Composition of the micelle, liposome and nanoemulsion droplet.1,3
This nanoscale droplet size is the core of their utility, conferring unique properties:
High Interfacial Area
Optical Clarity
Their small size prevents light scattering, making O/W nanoemulsions appear transparent or translucent, which is often desirable for pharmaceutical and cosmetic applications.
Kinetically Stable
Unlike macroemulsions, NEs exhibit superior kinetic stability against common physical instability mechanisms like sedimentation, creaming, and flocculation, allowing for prolonged storage.
The principles of NE technology, which leverages high- or low-energy methods (such as high-pressure homogenization or phase inversion temperature) for preparation, have been extensively documented in biopharmaceutical literature. For instance, the use of NEs to deliver hydrophobic drugs like paclitaxel or cyclosporine has demonstrated their capacity to surpass the intrinsic limitations of aqueous solubility, providing evidence of their vital role in next-generation drug formulation.
Applications of Nanoemulsion Delivery Systems
The versatility and performance enhancements offered by nanoemulsion platforms have secured their place across numerous therapeutic and cosmetic domains. Their ability to manage solubility and penetrate complex biological barriers makes them an indispensable tool.
Key Application Areas:
Oncology and Targeted Therapy
Nanoemulsions can passively accumulate at tumor sites via the Enhanced Permeability and Retention (EPR) effect due to their small size. When actively functionalized with ligands (e.g., peptides or antibodies), they can target specific cancer cell receptors, leading to high local drug concentrations and reduced systemic toxicity.
Topical and Transdermal Delivery
NEs facilitate the effective transport of both lipophilic and hydrophilic active compounds across the stratum corneum barrier. Their components can modify the skin's barrier properties, resulting in superior permeation for dermal treatments, including anti-inflammatory, antifungal, and cosmetic agents.
Ocular and Pulmonary Delivery
Due to their low viscosity and small particle size, NEs are ideal for formulating stable and non-irritating solutions for the eyes and lungs, maximizing drug retention time and absorption into these sensitive tissues.
Oral Drug Delivery
NEs are employed to protect drugs from harsh gastrointestinal environments and to promote lymphatic absorption, bypassing first-pass metabolism and significantly boosting the oral bioavailability of poorly soluble drugs.
Vaccine Adjuvants
In immunological applications, NEs can act as effective adjuvants, co-delivering antigens and stimulating a robust immune response by facilitating targeted uptake by antigen-presenting cells.
Practical Research Case Studies
Ocular Delivery
Nanoemulsion Based Vehicle for Effective Ocular Delivery of Moxifloxacin Using Experimental Design and Pharmacokinetic Study in Rabbits
Researchers optimized a moxifloxacin-loaded O/W nanoemulsion (<100nm) for ophthalmic delivery. In vivo rabbit studies demonstrated that the NE formulation significantly enhanced the drug's corneal permeation and extended its residence time in the aqueous humor compared to commercial eye drops. This improved bioavailability offers the potential for reduced dosing frequency and enhanced antimicrobial efficacy in treating ocular infections.2,3
What We Can Offer
Nanoemulsions (NEs) are critically important for drug candidates facing solubility, stability, or poor absorption challenges. At Creative Biolabs, our solution is engineered to deliver results that translate directly into clinical success. We focus on transforming challenging molecules, such as highly lipophilic drugs, poorly water-soluble compounds, and sensitive nucleic acids, into highly effective and patient-compliant dosage forms.
Specific Deliverables and Solutions:
Enhanced Bioavailability
We formulate NEs that dramatically increase the surface area available for absorption, particularly crucial for BCS Class II and IV drugs, ensuring your therapeutic reaches the intended concentration in vivo.
Targeted Efficacy
Our systems can be functionalized with specific targeting ligands, enabling active delivery to diseased tissues (e.g., tumors, inflamed sites) and minimizing off-target toxicity.
Stability and Shelf Life
We develop kinetically stable NE formulations that shield the active pharmaceutical ingredient (API) from degradation factors like oxidation, hydrolysis, and enzymatic activity, thereby extending the product's shelf life.
Versatile Administration Routes
We deliver formulations optimized for various routes, including oral, dermal, ocular, and intravenous injection, expanding the market potential and patient convenience of your drug product.
FAQs
What are the primary formulation barriers when developing a new nanodroplet delivery system?
The most common hurdles involve selecting the optimal oil, surfactant, and co-surfactant ratio to achieve long-term kinetic stability and ensure the final droplet size is consistently within the 20-200 nm range. It also requires achieving high drug encapsulation efficiency without sacrificing stability. Discussing your API's physicochemical properties early is key to overcoming these challenges; we encourage you to reach out for a custom formulation assessment.
How do these systems improve the absorption of a poorly water-soluble compound compared to traditional formulations?
The remarkable increase in absorption is due to the small droplet size, which maximizes the surface area for diffusion across membranes. Furthermore, the oily phase can enhance drug solubility, and the formulation components may temporarily disrupt biological barriers, allowing for faster and more complete uptake of the active compound. A discussion about your specific therapeutic target can help determine the most effective strategy.
Is it possible to modify the system for targeted delivery to a specific cell type, such as cancer cells?
Absolutely. While the small size allows for some passive accumulation in tumors (EPR effect), active targeting is achieved by chemically linking specific ligands—like peptides, aptamers, or antibodies—to the surface of the nanodroplets. This customization ensures the therapeutic is concentrated precisely at the site of action, which significantly boosts efficacy and reduces off-target side effects.
Are these systems appropriate for delivering sensitive macromolecules, like certain proteins or nucleic acids?
Yes, these systems provide an excellent environment for protecting sensitive payloads. The dispersed phase (oil or water) shields the macromolecule from enzymatic degradation and harsh pH conditions in vivo. For nucleic acids, the careful selection of cationic lipids or stabilizing components within the system is critical for protection and subsequent cellular uptake. Let's discuss your specific macromolecule to tailor the optimal protective formulation.
Creative Biolabs is fully equipped to be your single-source partner for the development and optimization of Nanoemulsion-based Delivery Systems. Our expertise spans initial formulation screening, comprehensive characterization, functionalization for targeted delivery, and robust scale-up support, ensuring your challenging drug candidates are transformed into stable, bioavailable, and therapeutically effective products. We are dedicated to delivering precision formulation solutions that accelerate your product development timeline.
Reference
- Mustafa, Isshadiba Faikah, and Mohd Zobir Hussein. "Synthesis and Technology of Nanoemulsion-Based Pesticide Formulation." Nanomaterials (Basel, Switzerland) vol. 10,8 1608. 17 Aug. 2020, https://doi.org/10.3390/nano10081608.
- Shah, Jigar et al. "Nanoemulsion Based Vehicle for Effective Ocular Delivery of Moxifloxacin Using Experimental Design and Pharmacokinetic Study in Rabbits." Pharmaceutics vol. 11,5 230. 11 May. 2019, https://doi.org/10.3390/pharmaceutics11050230.
- Distributed under Open Access license CC BY 4.0, without modification.
Our services are For Research Use Only. We do not provide services to individuals.
Online Inquiry
